E71.52 Category · further specificity required X-linked adrenoleukodystrophy
ICD-10-CM E71.52 identifies “X-linked adrenoleukodystrophy” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
No additional notes.
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E71.5 · Peroxisomal disorders
Excludes 11
Schilder's disease (G37.0)
More specific codes
E71.520Childhood cerebral X-linked adrenoleukodystrophyBillable / specificE71.521Adolescent X-linked adrenoleukodystrophyBillable / specificE71.522AdrenomyeloneuropathyBillable / specificE71.528Other X-linked adrenoleukodystrophyBillable / specificE71.529X-linked adrenoleukodystrophy, unspecified typeBillable / specificOfficial index references
References from other codes (1)
Excludes 1 · X linked adrenoleukodystrophy (E71.52-)
History
Code history
Latest recorded change · FY2024
Effective from
- Inherited rules changed
X-linked adrenoleukodystrophy
Category — select a more specific code
CDC/NCHS · FY2024All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | Inherited rules changed |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.